Does Good Science Lead to Valuable Knowledge? Biotechnology Firms and the Evolutionary Logic of Citation Patterns

By Michelle Gittelman, Bruce Kogut. Management Sciences, 2003

722 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Management of Technology and Innovation, Strategy and Management

View Paper: https://www.semanticscholar.org/paper/bd936e088b6f429b551c1228c13314c4262dcb5e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

In Management of Technology and Innovation

In Strategy and Management

Citations in the corpus

The Impact of Social Capital on the Start-ups’ Performance Growth (2010, background): “The weak social relationships furnish the tie with disparate segments of the social network that are otherwise unconnected and may open the door of a start-up to realize new options useful to its innovation process (Gittelman and Kogut 2003; Tripsas 1997; Burt 1992).”
When birds of a feather don’t flock together: Different scientists and the roles they play in biotech R&D alliances (2013, background): “ittelman and Kogut (2003) show that high-impact innovations n the biotechnology industry do not come from a firm’s capaility to produce ‘good science’ alone but rather are enhanced hrough the firm’s efforts to bridge the gap between science and nnovation—namely, employing scientists who are capable ”
The role of academic inventors in entrepreneurial firms: sharing the laboratory life (2004, background): “The prevailing view of the characteristics of these firms generally privileges firm-specific attributes or firm–scientist dyadic relationships based on human capital (Pisano, 1990; Calabrese et al., 2000; Zucher, Darby and Brewster, 1998; Stuart et al., 1999; Gittelman and Kogut, 2003; Shan et al., ”
Complementary technologies, knowledge relatedness, and invention outcomes in high technology mergers and acquisitions (2009, background): “Basic research still plays an important role (Turney, 2 Empirical studies have considered patents as a representation of technology, while papers and citations to them are viewed as representations of science (Meyer, 2000; Gittleman and Kogut, 2003).”
Not All Scientists pay to be Scientists (2014, positive): “On the other hand, firms may also see certain advantages to using a pro-publishing open science regime, including better access to extramural knowledge (Cockburn and Henderson, 1998; Gittelman and Kogut, 2003), strategic benefits when competing against rivals (Penin, 2007; Pacheco-de-Almeida and Zem”
Does Patent Strategy Shape the Long-Run Supply of Public Knowledge? Evidence from Human Genetics (2009, background): “This parallels the countervailing concern that firms contributing to the public knowledge stream weaken their ability to generate private knowledge (Gittelman & Kogut, 2003).”
Value creation in university-firm research collaborations: a matching approach (2008, positive): “In line with the existing empirical literature, I measure firms' scientific capabilities as the average number of publications over a ten year window before the collaboration year (DeCarolis and Deeds, 1999; Gittelman and Kogut, 2003).”
A Taste for Science? PhD Scientists’ Academic Orientation and Self-Selection into Research Careers in Industry (2010, positive): “…academic roots (e.g., founded by faculty members), they may also have a more “academic” atmosphere, potentially allowing their employees to interact more freely with the scientiﬁc community (Etzkowitz, 1998; Zucker et al., 2002; Gittelman and Kogut, 2003; Owen-Smith and Powell, 2004; Ding, 2009).”
1 Moving Beyond Schumpeter: Management Research on the Determinants of Technological Innovation (2008, background): “Gittelman and Kogut (2003) highlight that the pursuit of good science does not naturally coincide with the pursuit of valuable innovations.”
A capability-based view of competitive heterogeneity (2008, background): “from different forms of recombination such as: combining established technical capabilities with breakthrough technologies (Patel and Pavitt, 2000); combining knowledge and capabilities of scientists operating within and across a firm’s boundaries (Gittelman and Kogut, 2003); and combining existing ”